Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
RSM Kilitch Pharma Private Limited, now operating as Trigenesis Biosciences Private Limited, is an Indian pharmaceutical company headquartered in Bangalore. The company specializes in the development, manufacturing, and marketing of a diverse range of pharmaceutical formulations, with a strong emphasis on sterile injectables and antibacterial parenterals. RSM Kilitch provides high-quality generic medicines, including antibiotics, analgesics, and gastrointestinal treatments, to healthcare providers across India and international markets. The company has a significant history as a contract manufacturing partner for major global pharmaceutical firms such as Sandoz, Cipla, and Lupin, leveraging its WHO-GMP certified production facilities. Its product portfolio features well-known brands like Atsofine, Etorent, and Vinocef, addressing critical therapeutic needs in infectious diseases and hospital care.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on RSM Kilitch Pharma.